Stribild Lawsuit | 2025 Latest Updates

Lawsuits are being filed against Gilead Sciences Inc. alleging that Stribild and its other tenofovir-containing HIV drugs have the potential to cause toxicity to the kidneys and bone density loss.
Award Logos
C.L. Mike Schmidt Published by C.L. Mike Schmidt

Free Confidential Stribild Lawsuit Consultation
If you or a loved one think you may have a claim, you should contact a personal injury lawyer immediately.

You may be entitled to recover compensation and our legal team can help. Please click the button below for a Free Consultation or call us toll-free 24 hrs/day for legal advice by dialing (866) 588-0600.

Start My Free Case Evaluation

Bone Mineral Density

Stribild Lawsuit Overview

Lawsuits are being filed against Gilead Sciences Inc. alleging that Stribild and other tenofovir-containing HIV drugs cause kidney toxicity and bone density loss. The litigation focuses on claims that Gilead failed to adequately warn patients about these serious Stribild side effects. AIDS Healthcare Foundation filed a class action lawsuit representing Stribild users in May 2018.

Latest Stribild Lawsuit Updates

  • July 25, 2024 – U.S. District Judge Jon S. Tigar has greenlighted a lawsuit filed by patients accusing Gilead Sciences of negligence and product liability surrounding its tenofovir disoproxil fumarate-containing HIV drugs, while narrowing the scope by dismissing allegations that Gilead hid knowledge that the medicines are “unreasonably and unnecessarily unsafe.”
  • May 2018 – AIDS Health Foundation (AHF), the largest global AIDS organization, filed lawsuits on behalf of Devin Martinez, Ricardo Wohler, and other Stribild users who purchased Stribild and other HIV medicines.

FDA Reports and Statistics

According to studies cited in the litigation, Stribild and other tenofovir-containing HIV medications have been linked to significant adverse events. FDA approved Stribild in October 2012 [1], and tenofovir disoproxil fumarate (TDF) was initially approved in 2001.

The FDA reprimanded Gilead in 2002 and 2003 for claiming the drug had no toxicities and would not cause bone or kidney damage, yet the company continued to downplay the risks according to lawsuit allegations.

Gilead Sciences Inc

Stribild Injuries & Side Effects

Stribild contains tenofovir disoproxil fumarate, which has been linked to severe kidney and bone-related complications, as reported by a 2023 research [2]:

  • Kidney Problems: Reduced kidney function, kidney injuries, kidney damage, kidney toxicity, kidney disease (CKD), kidney failure (renal failure)
  • Bone Complications: Increased risk of bone demineralization, decreased bone mineral density, bone fractures, osteopenia, osteoporosis
  • Other Serious Effects: Liver problems, buildup of lactic acid in the blood (lactic acidosis), chronic pain

Medical Devices

Stribild: Benefits and Risks

Stribild is an nucleoside reverse transcriptase inhibitor (NRTI) that works by blocking the reverse transcriptase (RT) enzyme, which HIV uses to replicate. While it doesn’t cure HIV/AIDS, Stribild prevents HIV cells from multiplying and, when combined with other medications, can reduce viral load.

Clinical studies demonstrated Stribild’s effectiveness: in the first study of 715 patients, approximately 90% of previously untreated adults (316 out of 353) showed reduced viral loads after 48 weeks compared to 87% (308 out of 355) with alternative treatments.

In a second study involving 707 patients, 88% (305 out of 348) responded positively versus 84% (296 out of 352) with the comparator medicine.

A third study with 50 adolescents aged 12-18 showed 88% (44 of 50) responded after 24 weeks, with results maintained at 48 weeks [3].

Stribild provides viral suppression, comparable to other combination HIV drugs through review of non-inferiority and regimen simplification studies, with minimal adverse effects. Although the breadth of Stribild effectiveness has begun to unfold, studies are lacking in older patients as well as adolescents. Stated the National Library of Medicine.

However, Stribild’s benefits come with significant risks. Because TDF is poorly absorbed, patients must take high doses, leading to serious potential side effects. Studies have confirmed that prolonged use can cause acute kidney disease, cancer, and osteoporosis at alarmingly high rates.

Which Other HIV Drugs Contain Tenofovir?

In addition to Stribild, other HIV medications that contain tenofovir include:

European ScientistsDo You Qualify for a Stribild Lawsuit?

You may qualify for a Stribild lawsuit if:

  • You used Stribild as prescribed by your doctor.
  • You experienced serious side effects including kidney damage or bone density loss.
  • The injuries required medical treatment or hospitalization.
  • You can provide medical documentation linking your injuries to Stribild.

Evidence Required for a Stribild Lawsuit

  • Medical records documenting your HIV diagnosis and Stribild prescription
  • Medical documentation of kidney damage, bone density loss, or other serious side effects
  • Evidence showing a connection between your injuries and Stribild use

Damages You Can Recover

  • Medical expenses (current and future)
  • Lost wages
  • Pain and suffering
  • Other related costs

Read more: Can I File a Stribild Class Action Lawsuit?

FAQs

1. What is Stribild?

Stribild is an HIV medication made by Gilead Sciences that was approved by the FDA in October 2012. It treats human immunodeficiency virus (HIV) but doesn’t cure HIV or AIDS.

2. What is the basis for Stribild lawsuits?

Lawsuits allege that Gilead failed to adequately warn doctors and patients about the risk of kidney damage and bone problems associated with Stribild and other tenofovir-containing HIV medications.

3. What are the allegations against Gilead in the class lawsuit?

Allegations include failing to disclose significant risks of toxicity and bone and kidney damage, failing to warn of risks in all patients, and misrepresenting the risks and benefits of TDF drugs.

4. How does Stribild work?

Stribild is a combination drug with a component belonging to a group of pharmaceuticals known as NRTIs (nucleoside reverse transcriptase inhibitors). It blocks the reverse transcriptase enzyme, preventing HIV cells from multiplying.

5. What were the results of Stribild studies?

In clinical studies involving 1,422 adult patients, around 88-90% of patients treated with Stribild responded to treatment after 48 weeks, showing viral load reduction to less than 50 HIV-1 RNA copies/ml.

6. What other HIV drugs contain tenofovir?

Other HIV medications that contain tenofovir include Complera, Atripla, Truvada, and Viread.

7. What are the symptoms of chronic kidney disease related to Stribild?

Symptoms include weight loss, poor appetite, swollen extremities, shortness of breath, tiredness, blood in urine, increased urination, difficulty sleeping, itchy skin, muscle cramps, and headaches.

8. How can filing a lawsuit help me?

Filing a lawsuit may help you collect compensation for medical expenses, lost wages, and pain and suffering, while also holding the manufacturer accountable.

See all related dangerous drug lawsuits our attorneys covered so far.

Get a Free Stribild Lawsuit Evaluation With Our Lawyers

Time is limited to pursue legal action for Stribild-related injuries. If you or a loved one suffered kidney damage, bone density loss, or other serious side effects after taking Stribild, contact Schmidt & Clark, LLP attorneys immediately.

We offer:

Choose our lawyers

Have you or a loved one suffered from the adverse side effects caused by defective medication?

References

  1. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=74ae2a93-b267-444c-8f0f-a2a6522260ee
  2. https://www.healthline.com/health/drugs/stribild#drug-images
  3. https://www.ema.europa.eu/en/medicines/human/EPAR/stribild

Get a Free Case Review

You may be entitled to financial compensation.
  • This field is for validation purposes and should be left unchanged.
Secure Submission